Assertio Therapeutics

Yahoo Finance • last year

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that ma... Full story

Yahoo Finance • last year

Assertio Reports Third Quarter 2023 Financial Results

Closed Spectrum Acquisition on July 31, 2023, which diversifies and extends portfolio duration Cash balance at September 30, 2023 of $76.9 million Announces Management Updates LAKE FOREST, Ill., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assert... Full story

Yahoo Finance • last year

Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023

LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will rele... Full story

Yahoo Finance • last year

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective October... Full story

Yahoo Finance • last year

12 Best High Risk Penny Stocks to Buy Now

In this article, we will take a look at the 12 best high risk penny stocks to buy now. To see more such companies, go directly to 5 Best High Risk Penny Stocks to Buy Now. Investors are jubilant over Nvidia crushing analyst estimates in i... Full story

Yahoo Finance • last year

Assertio Holdings Joins Russell 3000® Index

LAKE FOREST, Ill., June 26, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company, today announced that it has joined the broad-market Russell 3000 Index as part... Full story

Yahoo Finance • last year

IMPORTANT ALERT: Halper Sadeh LLC Investigates AMED, ASRT, SYNH, TESS

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook

Net Product Sales Increase 18% Year-Over-Year Raises Full Year Outlook to Net Product Sales of $157 to $167 Million, Adjusted EBITDA $90 to $98 Million To Acquire Spectrum Pharmaceuticals in All Stock and CVR Transaction, Expected to be... Full story

Yahoo Finance • 2 years ago

Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern Time

Assertio Holdings, Inc. LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today annou... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of HOTH, ASRT, SPPI, and CEI

NEW YORK, April 29, 2023 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of HOTH with Algorithm Sciences, In... Full story

Yahoo Finance • 2 years ago

Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

LAKE FOREST, Ill., April 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will rel... Full story

Yahoo Finance • 2 years ago

Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Per... Full story

Yahoo Finance • 2 years ago

Assertio Provides Educational Grant for New Lennox-Gastaut Syndrome (LGS) Foundation Treatments Kits

SYMPAZAN (clobazam) oral CIV film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older Oral film delivery from SYMPAZAN® delivers clobazam to LGS patients with no crushi... Full story

Yahoo Finance • 2 years ago

Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV

LAS VEGAS, NV / ACCESSWIRE / April 24, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino... Full story

Yahoo Finance • 2 years ago

Q4 2022 Aquestive Therapeutics Inc Earnings Call

Participants A. Ernest Toth; Senior VP & CFO; Aquestive Therapeutics, Inc. Bennett Watson Daniel Barber; CEO, President & Director; Aquestive Therapeutics, Inc. Kenneth W. Marshall; Senior VP & Chief Commercial Officer; Aquestive Thera... Full story

Yahoo Finance • 2 years ago

Assertio Reports Fourth Quarter and Full Year 2022 Financial Results

Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million Cash Flows from Operations Was $26.7 Million for the Fourt... Full story

Yahoo Finance • 2 years ago

Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical

LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced the appointment... Full story

Yahoo Finance • 2 years ago

Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027

LAKE FOREST, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced it has entered into separate, priv... Full story

Yahoo Finance • 2 years ago

Assertio Holdings, Inc. Announces Preliminary Fourth Quarter and Full Year 2022 Results

Year-over-Year Net Product Sales Increased at Least 54% for the Fourth Quarter and 41% for the Full Year Cash Flows from Operations Was at Least $26 Million for the Fourth Quarter and $78 Million for the Full Year To Report Fourth Quarte... Full story

Yahoo Finance • 2 years ago

Assertio to Participate in the 2023 Winter Wonderland Best Ideas Conference

LAKE FOREST, Ill., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert,... Full story